Wellington Management Group LLP Sarepta Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 2,068,771 shares of SRPT stock, worth $221 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,068,771

Previous 2,726,613 24.13%

Holding current value

$221 Million

Previous $341 Million 26.14%

% of portfolio

0.05%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$104.54 - $137.94 $68.8 Million - $90.7 Million	-657,842 Reduced 24.13%	2,068,771 $252 Million
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $82.7 Million - $104 Million	665,087 Added 32.26%	2,726,613 $341 Million
Q2 2024 Aug 13, 2024	SELL	$113.33 - $163.85 $134 Million - $194 Million	-1,184,272 Reduced 36.49%	2,061,526 $326 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $304 Million - $459 Million	3,245,798 New	3,245,798 $420 Million
Q4 2023 Feb 12, 2024	BUY	$67.31 - $124.76 $278 Million - $515 Million	4,127,610 New	4,127,610 $398 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $5.61 Million - $6.76 Million	54,698 Added 1.42%	3,909,800 $474 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $98 Million - $145 Million	921,490 Added 31.41%	3,855,102 $441 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $44.6 Million - $59.2 Million	379,548 Added 14.86%	2,933,612 $404 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $484,632 - $634,884	-4,805 Reduced 0.19%	2,554,064 $331 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $15.9 Million - $25 Million	-209,992 Reduced 7.58%	2,558,869 $283 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $5.54 Million - $7.82 Million	88,383 Added 3.3%	2,768,861 $208 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $42.5 Million - $60.9 Million	673,725 Added 33.57%	2,680,478 $209 Million
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $46.9 Million - $60.4 Million	607,291 Added 43.39%	2,006,753 $181 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $7.07 Million - $9.91 Million	-107,210 Reduced 7.12%	1,399,462 $129 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $763,318 - $954,423	-11,002 Reduced 0.72%	1,506,672 $117 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $15.1 Million - $35.4 Million	209,362 Added 16.0%	1,517,674 $113 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $3.31 Million - $4.71 Million	26,375 Added 2.06%	1,308,312 $223 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $19.2 Million - $26 Million	150,743 Added 13.33%	1,281,937 $180 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $17.3 Million - $31.9 Million	185,782 Added 19.65%	1,131,194 $181 Million
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $471,378 - $753,244	-5,722 Reduced 0.6%	945,412 $92.5 Million
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $72.8 Million - $129 Million	951,134 New	951,134 $123 Million

Others Institutions Holding SRPT

# of Institutions

535

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.35B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Sarepta Therapeutics, Inc. Transaction History